The additive prognostic value of end-systolic pressure-volume relation in patients with diabetes mellitus having negative dobutamine stress echocardiography by wall motion criteria

Heart

Volumn 95, Issue 17, 2009, Pages 1429-1435

  Cortigiani, Lauro ^a   Bombardini, T ^b   Corbisiero, A ^c   Mazzoni, A ^a   Bovenzi, F ^a   Picano, E ^b  

^a CAMPO DI MARTE HOSPITAL   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c Clinica Montevergine   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DOBUTAMINE;

AGED; ANGIOPLASTY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION; STRESS ECHOCARDIOGRAPHY; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE;

AGED; BLOOD PRESSURE; CARDIOTONIC AGENTS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 69249097910     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.161752     Document Type: Article

References (30)

1. Cortigiani L, Bigi R, Sicari R, et al. Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease. J Am Coll Cardiol 2006;47:605-10.
2. Cortigiani L, Rigo F, Gherardi S, et al. Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol 2007;50:1354-61.
3. Opie LH. Mechanisms of cardiac contraction and relaxation. In: Braunwald E, Zipes DP, Libby P, Bonow RO, eds. Heart disease. 7th ed. WB Saunders, 2005;chapter 19:457-89.
4. Bombardini T, Galderisi M, Agricola E, et al. Negative stress echo: further prognostic stratification with assessment of pressure-volume relation. Int J Cardiol 2008;126:258-67.
5. Bombardini T, Agrusta M, Natsvlishvili N, et al. Noninvasive assessment of left ventricular contractility by pacemaker stress echocardiography. Eur J Heart Fail 2005;2:173-81.
6. Grosu A, Bombardini T, Senni M, et al. End-systolic pressure/volume relations during dobutamine stress echo: a prognostically useful noninvasive index of left ventricular contractility. Eur Heart J 2005;26:2404-12.
7. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part I: Diagnosis and classification of diabetes mellitus. WHO/NCD/NCS/99.2. Geneva: WHO, 1999.
8. European Society of Hypertension-European Society of Cardiology. Guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
9. National Cholesterol Education Program Expert Panel. Third report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Full report. www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf, 2001.
10. Lang RM, Bierig M, Devereux RB, et al, Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
11. Picano E, Mathias W, Pingitore A, et al. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicenter study. Lancet 1994;344:1190-2.
12. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-72.
13. Cortigiani L, Lombardi M, Landi P, et al. Risk stratification by pharmacological stress echocardiography in a primary care cardiology centre. Experience in 1082 patients. Eur Heart J 1998;19:1673-80.
14. Bhargava V, Shabetai R, Mathiasen RA, et al. Loss of adrenergic control of the force-frequency relation in heart failure secondary to idiopathic or ischemic cardiomyopathy. Am J Cardiol 1998;81:1130- 7.
15. Hasenfuss G, Holubarsch C, Hermann HP, et al. Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. Eur Heart J 1994;15:164-70.
16. Izawa H, Yokota M, Takeichi Y, et al. Adrenergic control of the force-frequency and relaxation-frequency relations in patients with hypertrophic cardiomyopathy. Circulation 1997;96:2959-68.
17. Inagaki M, Yokota M, Izawa H, et al. Impaired force-frequency relations in patients with hypertensive left ventricular hypertrophy. Circulation 1999;14:1822-30.
18. Agricola E, Bombardini T, Oppizzi M, et al. Usefulness of latent left ventricular dysfunction assessed by Bowditch Treppe to predict stress-induced pulmonary hypertension in minimally symptomatic severe mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol 2005;95:41-7.
19. Picano E. Diabetic cardiomyopathy. The importance of being erliest. J Am Coll Cardiol 2003;42:454-7.
20. Strauer BE, Motz W, Vogt M, et al. Impaired coronary flow reserve in non-insulin dependent diabetes mellitus: a possible role for diabetic cardiopathy in humans. Diabetes 1997;46:S119-24.
21. Nasher PJ, Brown RE, Oskarsson H, et al. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995;91:635-40.
22. Nitenberg A, Ledoux S, Valensi P, et al. Impairment of coronary microvascular dilation in response to cold pressor-induced sympathetic stimulation in type 2 diabetic patients with abnormal stress thallium imaging. Diabetes 2001;50:1180-5.
23. Fang ZY, Yuda S, Anderson V, et al. Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol 2003;41:611-7.
24. Ha JW, Lee HC, Kang ES, et al. Abnormal left ventricualr longitudinal functional reserve in patients with diabetes mellitus: implication for detecting subclinical myocardial dysfunction using tissue Doppler echocardiography. Heart 2007;93:1571-6.
25. Mahrholdt H, Wagner A, Judd RM, et al. Delayed enhancement cardiovascular magnetic resonance assessment of nonischaemic cardiomyopathies. Eur Heart J 2005;26:1461-74.
26. Sabbah HN, Marzilli M, Stein PD. The relative role of subendocardium and subepicardium in left ventricular mechanics. Am J Phys 1981;240:H920-6.
27. Sabbah HN, Stein PD. Pressure-diameter relations during early diastole in dogs. Incompatibility with the concept of passive left ventricular filling. Circ Res 1981;48:357-65.
28. Kaul S. There may be more to myocardial viability than meets the eye. Circulation 1995;92:2790-3.
29. Rigo F, Sicari R, Gherardi S, et al. The additive prognostic value of wall motion abnormalities and coronary flow reserve during dipyridamole stress echo. Eur Heart J 2008;29:79-88.
30. Bombardini T, Gemignani V, Bianchini E, et al. Cardiac reflections and natural vibrations: force-frequency relation recording system in the stress echo lab. Cardiovasc Ultrasound 2007;5:42.